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Abstract
Background: Continuous emergence of multi-drug-resistant malaria parasites and their rapid spread across the
globe warrant urgent search for new anti-malarial chemotherapeutics. Traditional medicinal plants have been the
main sources for screening active phytochemicals against malaria. Accordingly, this study was aimed at evaluating
the anti-malarial activity of Osyris quadripartita Salzm. Ex Decne., a plant which is used for traditional malaria
treatment by local people in different parts of Ethiopia.
Methods: Aqueous, chloroform and methanol crude leaf extracts of the plant have been prepared and tested
for acute toxicity and anti-malarial efficacy in Plasmodium berghei (ANKA strain)-infected Swiss albino mice.
Results: At three oral doses of 200, 400 and 600 mg/kg the plant material was safe, chemosuppressive and thus
prevented body weight loss, hematological abnormalities and increased mice mean survival time compared to the
negative control. The most efficacious extract was that of chloroform which prolonged mean mouse survival past day
11 of infection with all the mice in this group having the highest parasitemia suppression rate (41.3 %, at 600 mg/kg)
although parasite clearance was not achieved compared to the standard drug (chloroquine) against the parasite.
Conclusion: The finding supports the traditional use of the plant for the treatment of malaria. However, further confirmatory
studies followed by isolation and characterization of the active anti-malarial compound (s) of the plant that is/are responsible
for the observed parasite suppression is needed before it is recommended for malaria drug search and discovery.
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Background
Though malaria mortality rates have fallen by 47 % glo-
bally and by 54 % in the World Health Organization
(WHO) African Region since 2000, about 198 million
cases and 584 000 deaths occurred in 2013 showing that
malaria is still among the leading human infectious
diseases with 90 % of the cases and deaths occurring in
Africa [1]. In Ethiopia, although evidences suggest a sub-
stantial decline in malaria cases and deaths in recent years
compared to the baseline year of 2004, the occurrence of
several isolated outbreaks was reported nationwide and
the disease remains a major cause of outpatient consult-
ation in the country [2].
Due to climatic changes and coupled-human-natural
factors malaria epidemiology is progressively changing
putting more people at-risk. Moreover, there is a rapid
emergence of drug-resistant Plasmodium strains. For
instance, resistance has already been developed against
the latest first-line anti-malaria drug, artemisinin, in Asia
[3]. Malaria control efforts are further complicated by
the increased resistance of mosquito vectors to insecti-
cides [4] together with challenges of having effective
anti-malaria vaccines. Thus, there is urgent need to
search for effective, easily available, affordable and safe
alternative anti-malaria drugs that can be integrated into
the existing malaria control interventions to successfully
curtail the disease and for its eventual elimination or
eradication.
It is well-known that plants have been and are still the
mainstay of traditional medicine against malaria and
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other diseases in resource-limited settings as over
one-third of the population in such countries lack access
to essential medicines [5]. However, the claimed potency
of medicinal plants has to be scientifically evaluated and
toxicological studies should be done. Rigorous in vitro
and in vivo toxicological investigations are required to
determine the type and degree of toxicity, safety and
efficacy of plant products in malaria drug research and
ultimate discovery as well as to recommend or discour-
age a plants’ traditional medicinal use.
To this end, various studies have been conducted to
evaluate the safety and anti-malarial efficacy of trad-
itionally used plants in Asia and Africa. For example,
Ramazani et al. [6] worked on ten Iranian plant
species but only - Boerhavia elegans, Solanum surat-
tense and Prosopis juliflora – showed a promising
anti-plasmodial activity in vitro and in vivo with no
toxicity. Verma et al. [7] reported that Holarrhena
antidysenterica and Viola canescens exhibited in vitro
anti-plasmodial activity in Himalaya. From sub-Saharan
Africa in Burkina Faso [8], promising in vitro anti-
plasmodial results were obtained for the plant Dicoma
tomentosa with the dichloromethane, diethylether, ethyla-
cetate and methanol extracts demonstrating a high
activity. In the same study hot water and hydroethanolic
extracts also showed a good activity, which was also
confirmed in vivo for all tested extracts.
Despite their wide use in the traditional healthcare,
the work that has been done to evaluate the safety and
efficacy of Ethiopian traditional medicinal plants is
relatively less extensive. A number of traditional medi-
cinal plants remain unevaluated. Osyris quadripartita
which is commonly used in Ethiopian traditional medi-
cinal practices [9–12] and elsewhere in Africa [13] is a
case in point. Specifically, the leaf of this plant is used to
traditionally treat malaria [14, 15] in Ethiopia and cancer
in Algeria [16]. The anti-inflammatory property of a
methanol extract of O. quadripartita was demonstrated
in effectively reducing increased capillary permeability
induced in rats by various chemical mediators [17]. The
antioxidant effect of this plant species has also been
evaluated and was found to be good [18]. The plant has
anti-bacterial and anti-fungal activities [19]. According
to this same work, the plant was active against Gram-
negative bacteria such as Escherichia coli and Pseudo-
monas aeruginosa as well as Gram-positives like
Staphylococcus aureus. Though its effect was relatively
lesser compared to other parallel test extracts the
plant crude extract had a comparable efficacy to that
of the positive control (gentamicin sulphate). The
anti-bacterial and anti-fungal effects of O. quadripar-
tita were confirmed by a latter more comprehensive
study [20]. A different species within the genus,
Osyris alba, which was tested against Entameba
histolytica, Giardia intestinalis and Candida albicans
has shown a reasonable effect [21].
Phytochemical studies on the genus Osyris has yielded
hexyl and hexenyl derivatives, sesquiterpenes, phenolic
acids, flavoinoids, pyrrolizidine and quinolizidine alka-
loids, long chain hydrocarbons and fattyacids, triter-
penes, dihydro-β-agarofuran sesquiterpenes, phenolics
phenyl propanoids and lignans [17, 21–26]. However,
the possible anti-plasmodial effect of the genus was not
tested in vivo and in vitro either. The aim of this study
was, therefore, to assess the anti-plasmodial activity and
safety threshold of O. quadripartita in Swiss albino mice
in an attempt to contribute towards screening traditional
medicinal plants for malaria control.
Methods
Plant description
The genus Osyris which includes more than 34 spe-
cies belongs to the family Santalaceae and the species
O. quadripartita Salzm. ex Decne. (locally called qeret
in Amharic and wato in Afaan Oromoo) is an evergreen,
dioecious tree or shrub reaching a height of 1–7 m with
many branches and the branches sometimes pendant [27].
It is hemiparasitic and sometimes opportunistically taps
into the root systems of nearby plants and parasitizes
them although it can freely grow and survive [28, 29]. The
plant which is native to Africa, southwestern Europe and
Asia is commonly known as wild tea plant [30]. This plant
is widely distributed in Ethiopia [27].
Sample collection
Leaf samples of O. quadripartita were collected in
December 2013 from its natural habitat in Wertu kebele
around Fiche Town, some 110 km north of Addis
Ababa. Previous ethnobatanical studies characterized
Fiche and its flora in relation to traditional medicinal
values [31, 32]. The collected plant sample for this study
was identified and authenticated by the second author
who is an ethnobotanist at Aklilu Lemma Institute of
Pathobiology, Addis Ababa University (AAU) and the
voucher specimen was deposited in the National Herbar-
ium of AAU with voucher number designated as Senait
001/2014.
Preparation of crude plant extracts
The leaf tissues were washed thoroughly with running
tap water and each plant material was reduced to
smaller fragments. The washed leaves were air dried at
a room temperature under shade in the Biomedical
Sciences Laboratory, Department of Microbial, Cellular
and Molecular Biology (DMCMB); College of Natural
Sciences (CNS), AAU and were ground into fine powder
using an electric grinder and kept in a tightly closed
brown bottle until used for extraction.
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The leaf crude extracts of aqueous, 98 % methanol
and chloroform were prepared by the established cold
maceration technique [33]. Briefly, a 100 g plant ex-
tract material was refluxed in 1000 ml of aqueous,
methanol or chloroform and the respective mixtures
were placed on an orbital shaker (GFL, model 3020,
Germany) at 160 revolutions per minute (rpm) for
72 hours. The mixture was first filtered using cotton
and then the filtrate was passed through Whatman
filter paper №3, 15 cm pore size with retention down
to 0.1 μm in liquids (Whatman LTD, England). The
methanol and chloroform extracts were concentrated in a
rotary evaporator (Buchi type TRE121, Switzerland) at a
temperature of 45 °C; whereas the aqueous extract was
freeze-dried using centrifugal freeze dryer (Model 5 PS,
Christ, England). All the extracts were stored in screw cap
vials at −20 °C until used for the in vivo experiment.
Acute toxicity test
The aqueous and methanol extracts of the plant ma-
terial were dissolved in 10 ml of distilled water
(dH2O) and that of chloroform was dissolved in 3 %
Tween (T)-80 prior to the actual experiment, the
chloroform extract failed to dissolve in dH2O. Indi-
vidual body weights (BW) of mice were determined
and recorded shortly before and after the plant was
administered to evaluate its toxicity as per the
Organization for Economic Co-operation and Devel-
opment (OECD) Guidelines for the Testing of Chemi-
cals [34]. For this purpose non-infected female mice
aged 6–8 weeks (mean age 7.4 weeks) and weighing
23-38 g (mean weight 28.35 g) were used.
Twenty mice were used by randomly dividing them
into four groups of 5 mice per cage. The mice were
starved for 3–4 hrs before the experiment began with
only water allowed and 1–2 hrs after the extracts were
given. Then, the mice in groups 1, 2 and 3 were orally
given 1000, 1500 and 2000 mg/kg BW in single dose vol-
ume of 0.2 ml of the extract, respectively. The mice in
the negative control group received 0.2 ml of dH2O or
T-80. Then, the mice were monitored continuously for
1 hr, intermittently for 4 hrs and for a period of 24 hrs
for any gross behavioral changes such as rigidity, sleep,
mortality and other signs of acute toxicity manifesta-
tions, and the follow-up continued for 28 days [35].
Parasite inoculation and anti-malarial assays
Parasite inoculation and maintenance
When working on chloroquine (CQ)-sensitive P. ber-
ghei CQ is employed as a standard positive control
[36] and in this study a similar study design was
followed. Previously maintained Swiss albino mice 5–
7 weeks of age were used for the test. CQ-sensitive
strain of P. berghei (ANKA strain) previously
maintained in the DMCMB animal house were used
for the experiment. Female mice having variable para-
sitaemia level were used as donor animals. The para-
sitaemia of the donor mice was first determined and
parasitized erythrocytes were obtained by cardiac
puncture using ethyl ether as anesthesia and sodium
citrate (0.5 %) diluted in physiological saline (0.9 %)
as an anticoagulant. The dilution was made based on
the parasitaemia of the donor mice and the erythro-
cyte count of normal mice in such a way that 1 ml
blood contains 5x107 infected erythrocytes [37]. Each
mouse was inoculated by intra-peritoneal injection
with a blood suspension (0.2 ml) containing 1x107
parasitized erythrocytes. The parasite was maintained
by serial passage of blood from infected mice to non-
infected ones on a weekly basis.
Anti-malarial activity
The standard four-day suppressive method was used
in screening of the plant extracts [36]. The experi-
mental mice infected with 1x107 P. berghei each were
randomly divided into nine test groups and three
control groups (each for CQ as the standard anti-
malarial drug and dH2O or 3 % T-80 as negative con-
trols (NC). The test extracts were prepared in three
different doses (200, 400 and 600 mg/kg BW and CQ
at 25 mg/kg, and all including the vehicles were given
in a volume of 0.2 ml per mouse. The extracts were
administered as a single dose per day. Both the ex-
tract and the drug were given through intra-gastric
route by using a standard intra-gastric tube to ensure
safe ingestion.
Chemosuppression
Treatment was started after 3 hrs of infection with
P. berghei on day 0 (D0, inoculation day) and was
continued daily for four days (i.e. from D0 to D3).
On the fifth day (D4) a blood sample was collected
from the tail snip of each mouse. Thin smears were
prepared, stained with 10 % Giemsa solution and
scanned under the light microscope with an oil
immersion objective of 100x magnification power fol-
lowing established procedure [38]. Then, the percent
suppression of each extract with respect to the con-
trol groups and the parasitaemia was determined by
counting a minimum of five fields per slide. Percent
of suppression (% suppression) and percent parasit-
aemia (% parasitaemia) were calculated in comparison
to the control using the method described by the
modified Peters and Robinson formula [39]:
%Suppression ¼ parasitasmia in negative control‐parasitasmia
in treated group
parasitasmia in negative control
X 100:
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% Suppression ¼ number of parasitized RBC
total RBC counted
X 100:
Determination of BW change
The BW of each mouse in all the groups was measured
before infection (D0) and on D4 in case of treatment, by
using a sensitive digital weighing balance (A&D Com-
pany LTD, Japan) and mean BW per group was calcu-
lated using the formula:
Mean BW ¼ mean body weightof mice in a group
total number of mice in that group
:
Determination of packed cell volume
Packed cell volume (PCV) was determined using blood
collected from tail of each mouse in heparinized micro-
haematocrit capillary tubes (Globe Scientific Inc, Pa-
ramus, NJ, USA) and filled up to 3/4th of the tube with
blood, sealed one end with crystal seal and placed with
the open end of the tube to the center and the sealed
end outwards of a microhaematocrit reader (Hawsksley
& Sons LTD, England). The blood was centrifuged at
12,000 rpm for 5 min and then the volume of the total
blood and the volume of erythrocytes were measured
using a ruler. Measurement was done before infection
and on D4 after infection. PCV was calculated using the
formula described by Gilmour and Sykes [40]:
PCV ¼ volume of total erythrcytes in a
given volume of blood
total blood volume
x 100:
Determination of mean survival time
Mortality was monitored daily and the number of days
from parasite inoculation up to death was recorded for
each mouse in the treatment and control groups
throughout the follow-up period. The mean survival
time (MST) for each group was calculated using the for-
mula below:
MST ¼ sum of survival time daysð Þ of mice in a group
total number of mice in that group
:
Ethical considerations
The study was conducted after ethical clearance was ob-
tained from CNS Institutional Ethics Review Board,
AAU. The living area for mice allowed them to satisfy
their basic needs including the ability to eat, drink, urin-
ate, defecate and also regulate their body temperature.
Overall there was a humane handling of the experimen-
tal mice throughout the study.
Data analysis
The PCV and BW of P. berghei-infected mice in each
group that were treated with the same extracts and dose
were compared between D0 and D4, the results were
expressed as mean plus or minus the standard error of
the mean (M ± SEM) by one way analysis of variance
(ANOVA) and 2-tailed Student’s t-test using statistical
package for the social sciences (SPSS) version 15 soft-
ware (SPSS IBM, Chicago, IL, USA). The suppressive
test results were analyzed by ANOVA followed by
Tukey-multiple comparison test to compare the level of
parasitaemia, and survival times of the infected mice be-
tween the control group and the extract treated groups
at a fixed time. All the data were analyzed at a 95 % con-
fidence interval. P-value less than 0.05 was considered
as statistically significant and <0.01 as highly significant.
Results
Extraction yield
The methanol extract of the plant material was the highest
yield followed by the aqueous and chloroform extracts
(Table 1). The differences between the yields were significant.
Acute toxicity test
The experimental mice who ingested crude leaf extracts of
the three solvents did not show any indication of gross
physical or behavioral changes such as hair erection,
reduction in feeding and motor activities, weight loss,
lacrimation, diarrhea, depression or abnormal secretions
within the 24 hrs monitoring period. No fatalities oc-
curred within the observation period of two weeks.
Anti-malarial activity
Effect of crude leaf extracts on PCV and BW
The aqueous, chloroform and methanol leaf extracts of O.
quadripartita demonstrated a dose-dependent effect on
the mean PCV value of P. berghei-infected mice (Table 2).
With increasing dose percentage change in PCV reduc-
tion was lowered for all the three extracts. Also, irrespect-
ive of extract type and dose there was reduction on mean
PCV on D4 though the difference was significant only for
the 200 mg/kg the aqueous, and 200 and 400 mg/kg
methanol extracts. But, when the results were compared
with the NC only 600 mg of the aqueous extract showed a
significant mean PCV reduction (p = 0.01).
A loss in BW was noticed for all groups of P. berghei-
infected mice four days post-extract-inoculation except
for those that ingested 400 and 600 mg/kg chloroform
extract. However, the percentage change in BW loss
decreased in a dose-dependent manner for all the three
extracts at the three doses. In the three groups of in-
fected mice that ingested the three different doses of the
aqueous and methanol extracts a significant BW loss
was recorded on D4 compared D0, but for the
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chloroform the difference was not significant. On the
other hand; while compared to the NC the change in
BW (for all the three doses) was significant for chloro-
form extract, it was not so for the other two. The in-
fected mice that were treated with 400 and 600 mg/kg
chloroform extract significantly gained BW.
Effect of crude leaf extracts on parasitaemia
Although there was clear regression of parasitaemia
among aqueous or methanol extract-treated mice, com-
pared to the NC, the difference was statistically signifi-
cant (p < 0.05) only for the methanol extract at 600 mg/
kg dose. With regard to the chloroform extract, however,
there was significant decline in % parasitaemia at all the
three doses in a dose-dependent manner. The maximum
parasitaemia reduction was 38.26 % (for the 600 mg)
compared to the figure for the NC group (65.4 %). The
evidence showed that the chloroform extract, was signifi-
cantly associated with lowered parasitaemia compared to
the NC as well as the other two concurrently tested ex-
tracts although the mice had still microscopically detect-
able parasitaemia.
Correspondingly, in all groups of extract-treated-mice para-
sitaemia were increasingly chemosuppressed in a dose-
dependent manner with the highest suppression being for
the chloroform extract - the highest (41.26 %, at 600 mg/kg
dose), mild (37.5 %, at 400 mg/kg), and the least (31.7 %, at
200 mg/kg).
Similarly, for the aqueous and methanol extracts all the
three doses, except that of aqueous at 200 mg/kg, were cor-
related with significantly increased mice survival compared
to the NC (dH20). The MST of chloroform extract-treated
mice was also significantly higher compared to the NC
(3 % T-80) groups and it was prolonged in a dose-
dependent manner (Table 3).
Discussion
While methanol yielded significantly higher extraction
efficiency, the chloroform extract was the lowest. The
probable reason for this variation could be due to high
concentration of polar compounds in the leaf of the
plant species that better dissolve in methanol which is a
polar solvent. The quality and quantity of phytochemi-
cals extracted from plant materials differ depending on,
Table 1 Yield of aqueous, chloroform and methanol crude leaf extracts ofO. quadripartita
Solvent Plant powder (g) Extraction solvent (ml) Yield (g) Yield (%)
Aqueous 100 1000 6.60 6.60*
Methanol 100 1000 32.75 32.75*
Chloroform 100 1000 1.447 1.447*
Key: ml = milliliter; g = gram; % = percentage; * = there was significant difference between these values (P < 0.05)





D0 D4 % change p-value** D0 D4 % change p-value**
Aqueous 200 60.4 ± 0.60 56.0 ± 0.89a −7.28 0.02, 0.05 31.2 ± 0.37 26.5 ± 0.76 a −15.06 0.000, 1.000
400 56.6 ± 1.28 54.0 ± 1.14 −4.59 0.17, 0.34 25.2 ± 0.37 21.8 ± 0.58 a −13.49 0.000, 0.005
600 58.6 ± 2.02 56.8 ± 1.98* −3.07 0.34, 0.01 28.6 ± 0.40 25.1 ± 0.47 a −12.23 0.000, 0.000
Methanol 200 58.4 ± 1.77 54.2 ± 1.46 a −7.19 0.02, 0.29 30.6 ± 0.40 26.4 ± 0.24 a −13.72 0.000, 1.000
400 57.0 ± 1.60 53.2 ± 1.20 a −6.67 0.04, 0.59 28.2 ± 0.37 24.6 ± 0.40 a −12.76 0.000, 0.522
600 59.4 ± 0.40 55.8 ± 0.73 −6.06 0.06, 0.06 25.6 ± 0.40 23.2 ± 0.37a −09.37 0.000, 0.112
Chloroform 200 57.2 ± 1.59 54.2 ± 1.31 −5.24 0.11, 0.29 27.6 ± 0.24 26.2 ± 0.37* −05.07 0.027, 0.000
400 56.4 ± 0.75 55.0 ± 0.54 −2.48 0.46, 0.34 28.6 ± 0.50 30.8 ± 0.58* +07.69 0.001, 0.000
600 54.8 ± 1.24 53.8 ± 1.52 −1.82 0.59, 0.17 27.0 ± 0.31 29.6 ± 0.40* +09.62 0.000, 0.000
dH2O (NC) 0.2 ml 56.8 ± 1.93 52.2 ± 1.71
a −8.09 0.017 29.0 ± 0.31 23.6 ± 0.24 a −18.62 0.000
T-80 (NC) 0.2 ml 58.0 ± 1.51 52.4 ± 0.92 a −9.65 0.004 28.8 ± 0.48 23.0 ± 0.44 a −20.13 0.000
CQ 25 56.8 ± 0.96 56.8 ± 0.89* 0.00 0.674 29.8 ± 0.48 33.2 ± 0.37*a +11.40 0.000
Keys: Values for the packed cell volume (PCV) and body weight (BW) are presented as mean (M) ± standard error of the mean (SEM); n = 5 (number of mice/group
in a single experiment); D0: day 0 (day-of-extract-inoculation); D4 = day 4 (the fifth day pos-extract-inoculation; mg/kg/day: 1mg of extract per one kilogram of
mice for one day; NC: negative control; T-80 = Tween-80 (NC for chloroform extract); dH2O: distilled water (NC for aqueous and methanol extract); CQ: chloroquine
phosphate; *: significant compared with that of NC; a: significant difference between D0 and D4. **the first value is for the comparison between D0 and D4, the
second is with the NC
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among other factors, the solvent type used. The com-
parative ability of extraction solvents of penetrating the
cellular membrane to extract the intracellular ingredi-
ents from the plant material may impact extract yield.
Some reports show that methanol extracts more number
and types of compounds in plant materials than other
extraction solvents such as aceton, chloroform, ether,
water and ethanol [41]. While chloroform is preferred to
extract terpenoids and flavonoids water is employed to
solubilize a wide range of plant metabolites like antho-
cyanins, starches, tannins, saponins, terpenoids, poly-
peptides and lectins. Methanol releases more diverse
phytochemicals such as anthocyanins, tannins, saponins,
terpenoids, xanthoxylines, totarol, quassinoids, lectones,
flavones, phenols and polyphenols [42].
The finding that the 3 % T-80, which was used as a
NC (for the chloroform extract) in the present study and
in which the extract was dissolved to deliver to the mice,
neither suppressed malaria parasitaemia in the infected
mice nor prevented weight loss and PCV depletion indi-
cated lack of possible T-related effect on the malaria
parasites.
Oral administration of the methanol, aqueous and
chloroform extracts of O. quadripartita did not show
changes in the general appearance or behavioral pattern
of the experimental mice until the end of 14 days. Fur-
ther, no death was observed in the animals receiving the
extract up to a dose of 2000 mg/kg BW, which is about
10 times the minimum effective dose tested (200 mg/kg).
If a test substance has a lethal dose (LD50) higher than
3 times the minimum effective dose, it can be a good
candidate for further studies [43]. Therefore, absence
of mortality up to an oral dose of 2000 mg/kg could
indicate that the test extracts were safe and this could
explain the routine use of the plant by the local people
for traditional management of malaria.
Significant BW increase among P. berghei-infected
mice four days after ingesting 400 and 600 mg chloro-
form crude leaf extract of O. quadripartita compared to
the untreated controls suggests the effect of the extract
in preventing malaria-related weight loss. It is well-
established that BW loss is one feature of murine
malaria [44]. The present result is in agreement with
other similar studies that reported mice BW loss using
different plant products and extraction solvents [45–47].
Lack of significant reduction in the mean BW among
aqueous and methanol extract-fed infected mice four
days post-treatment further signifies the positive effect
of the plant material on mice BW.
The absence of significant PCV reduction among
extract-treated mice at the doses of 200 and 400 mg/kg
of the aqueous extract may indicate the protective activ-
ity of the crude extract. Furthermore, observing a signifi-
cantly lower PCV reduction among the same groups of
mice at the highest dose (600 mg/kg) shows the pres-
ence of anti-malarial chemicals in the dose administered.
But it appears that the activity of the methanol extract
was not strong enough to significantly prevent PCV
reduction among P. berghei-infected mice. On the
contrary, the PCV of chloroform extract-treated mice
remained not significantly changed on D4, irrespective
of dose, underlining the protective role of the extract
against malaria.
The influence of malaria on hematological parameters
is extensively investigated and PCV reduction is consid-
ered a hallmark of both human and rodent malaria
(reviewed in Lamikanra et al. [48]. Infected mice may
suffer from severe malarial anemia because of rapid
Table 3 Chemosuppressive effect of crude aqueous, chloroform and methanol leaf extracts of O. quadripartita in P. berghei-infected mice
Description Dose (mg/kg/day) % parasitaemia p-value % suppression MST ± SEM p-value
Aqueous 200 63.02 ± 3.91 0.740 0.37 6.2 ± 0.37 0.418
400 54.62 ± 2.20 0.142 16.53 7.4 ± 0.51* 0.018
600 51.26 ± 2.05 0.056 21.67 8.2 ± 0.37* 0.001
Methanol 200 55.92 ± 0.84 0.196 14.5 7.4 ± 0.51* 0.018
400 50.94 ± 1.24 0.510 22.16 8.2 ± 0.37* 0.001
600 49.48 ± 2.06* 0.033 24.4 8.4 ± 0.24* 0.000
Chloroform 200 44.48 ± 10.18* 0.006 31.7 8.0 ± 1.14* 0.004
400 40.7 ± 9.66* 0.001 37.5 9.8 ± 0.58* 0.000
600 38.26 ± 8.78* 0.001 41.26 11 ± 0.63* 0.000
DH2O (NC) 0.2 ml 65.44 ± 1.7 - 0.00 5.6 ± 0.24
T-80 (NC) 0.2 ml 65.14 ± 1.7 - 0.00 5.8 ± 0.37
CQ 25 0.00 0.000 100 ND
Keys: mg/kg/day: 1 mg of extract per one kilogram of mice for one day; MST: mean survival time; SEM: standard error of the mean; NC: negative control;
T-80 = Tween-80 (NC for chloroform extract); dH2O: distilled water (NC for aqueous and methanol extract); CQ: chloroquine phosphate; ND: no death
*: significant compared with that of NC
Girma et al. BMC Complementary and Alternative Medicine  (2015) 15:184 Page 6 of 9
erythrocyte destruction, either by parasitaemia and/or
spleen reticulo-endothelial cells. For instance, in one
study it was noted that within an estimated 48 hrs of
post-infection rodent PCV was depleted to 43-44 % [49].
Further, P. berghei increased erythrocyte fragility and led
to subsequent reduction of PCV in infected-mice [50].
Multiple other in vivo studies on rodent malaria using
diverse plant species from Ethiopia as well as abroad
have reported similar results [6, 45–47, 51, 52]. Scarcity
of previous reports pertaining to anti-malarial activity of
O. quadripartita including the relative composition and
predominance of its leaf chemicals could not permit a
discussion from comparative perspective. Although the
antimicrobial [19, 20] and antiparasitic activities [21] of
O. quadripartita were investigated to some extent, its
plasmodial effect was little explored.
The 4-day suppressive test is a standard test commonly
used for in vivo anti-malarial phytochemical screening in
which ≥30 % reduction in parasitaemia following treat-
ment makes a product to be considered active [36, 43].
Accordingly, the chloroform extract of O. quadripartita
which showed 31.7 % suppression at the lowest, 37.5 % at
the medium and 41.26 % at the highest doses can be
classified as active. The dose-dependent variation in che-
mosuppression could be attributed to the low concentra-
tion of schizocidal compounds in natural products and as
such their activity may be undetectable in lower doses.
This increased percent suppression of parasitaemia with
increased dose was observed by other studies on different
plant species [45, 47, 53].
However, both the aqueous and methanol extract of
O. quadripartita didn’t display comparable suppressive
activity on P. berghei even at the highest dose delivered
(600 mg/kg). This at least undetectable level of anti-
malarial activity of aqueous and methanol crude leaf extract
of O. quadripartita may be an indication that the active
ingredients extracted by these solvents might have less
potent anti-malarial property. This can be explained by the
fact that some plants may contain chemicals that are more
soluble in polar solvents such as water, ethanol and metha-
nol while others contain chemicals that are more soluble in
non-polar solvents such as chloroform. Thus, the crude
aqueous or methanol extracts in the current study were
higher in terms of yield but they contained little com-
pounds that were efficacious at least against P. berghei.
A prolonged MST with significant difference, com-
pared to the NC, was observed for mice treated with all
the three extracts regardless of dose except for 200 mg/kg
of the aqueous extract implying the role of the plant
material in the control of murine malaria. Particularly, the
chloroform extract was highly associated with prolonged
MST even at the minimum dose implicating the dominant
presence of antimalarial bioactive compounds of the plant
tissue in this extract.
Nevertheless, the chloroform extract itself was less
effective compared to CQ, the standard drug against P.
berghei. CQ treatment (25 mg/kg) during the infection
seemed radically cleared parasitaemia or at least there
was no microscopically detectable parasitaemia. Rodent
malaria clinical manifestation like diarrhea, lethargy,
piloerection, reduced locomotor activity, etc. were non-
existent among the CQ-treated showing that the para-
sitological cure was clinical as well. Mice were appearing
and acting healthy on day 28. The undetectable level
clearance of parasitaemia following the CQ chemother-
apy indicates that the P. berghei strain used in the study
was highly sensitive to the drug and lends support that
this rodent malaria model system remains effective for
in vivo anti-malarial testing.
Conclusions
When orally administered, no adverse effects were noted
for the plant extracts ranging from 1000-2000 mg/kg
doses signifying the safety of the extracted phytochemi-
cals in mice via the oral route. The aqueous and metha-
nolic extracts showed some parasite suppressive effects
on P. berghei-infected mice in a dose-related fashion and
the chloroform extract was observed to have the stron-
gest activity although its effect was not comparable to
that of the standard drug which achieved parasite clear-
ance to undetectable level microscopically. The anti-
plasmodial activity as well as lack of toxicity of the crude
extract found in the present study may partly confirm
the claim by traditional practitioners about the use of
the plant against malaria. However, the finding is only
preliminary; and thus confirmatory studies followed by
isolation and characterization of the active anti-malarial
compound (s) of the plant that is/are responsible for the
observed parasite suppression thereby resulting in in-
creased MST, BW loss prevention and PCV reduction in
the P. berghei-infected mice are recommended.
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